Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis C (HCV) Genotype 5 Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis C (HCV) Genotype 5 Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis C (HCV) Genotype 5 Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 31 of 31 total samples
 (0)
Checkout
Advanced Data View:
Showing 31 of 31 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Detail 1Test 2Test Data 2Detail 2Product
Details
Price
Buy
Blood TypeCo-morbiditiesSymptoms3-series HepB VaccineIs Subject on Anti-Viral Therapy / TreatmentAcquired Infection CategoryAdditional TestingHCV Date of DiagnosisCurrent Anti-Viral Treatment or TherapiesFibroscanCo-InfectionsHepatitis Serology
BBP0000-AO900388056081418D3Hepatitis C (HCV) Genotype 5South AfricaPlasma1.00$250.0036 YFemaleNon-Hispanic<-70C14-Aug-18Roche COBAS AmpliPrep TaqMan3,425,00014-Aug-18NS5B Sequence5Genotype$250.00UnknownHep C and HIV | HIV Date of onset 2008No symptomsNoNoU/AALT: 81 U/L | AST: 54 U/L | ALP: 111 U/L | Bilirubin: 101 umol/L | Serum Creatinine: 58 umol/L
14-Aug-18
2018-07-24NoneF2
14-Aug-18
BBP0000-AO900388056081418D4Hepatitis C (HCV) Genotype 5South AfricaPlasma2.004.00$250.0036 YFemaleNon-Hispanic<-70C14-Aug-18Roche COBAS AmpliPrep TaqMan3,425,00014-Aug-18NS5B Sequence5Genotype$250.00UnknownHep C and HIV | HIV Date of onset 2008No symptomsNoNoU/AALT: 81 U/L | AST: 54 U/L | ALP: 111 U/L | Bilirubin: 101 umol/L | Serum Creatinine: 58 umol/L
14-Aug-18
2018-07-24NoneF2
14-Aug-18
BBP0000-AO900388068070518D1Hepatitis C (HCV) Genotype 5South AfricaPlasma4.003.00$250.0068 YFemaleNon-Hispanic<-70C05-Jul-18Roche COBAS AmpliPrep TaqMan4,970,0002-Jul-19NS5B Blast5Genotype$250.00UnknownHepatitis CDecreased appetite, Fatigue, Sleep disturbances, CirrhosisNoNoTransfusionALT: 37 U/L | AST: 30 U/L | ALP: 82 U/L | Bilirubin: 7 umol/L | Serum Creatinine: 91 umol/L
4-Jul-19
2018-05-15None69 kPa | F4
2-Jul-19
BBP0000-AO900388068070518D3Hepatitis C (HCV) Genotype 5South AfricaPlasma1.00$250.0068 YFemaleNon-Hispanic<-70C05-Jul-18Roche COBAS AmpliPrep TaqMan4,970,0002-Jul-19NS5B Blast5Genotype$250.00UnknownHepatitis CDecreased appetite, Fatigue, Sleep disturbances, CirrhosisNoNoTransfusionALT: 37 U/L | AST: 30 U/L | ALP: 82 U/L | Bilirubin: 7 umol/L | Serum Creatinine: 91 umol/L
4-Jul-19
2018-05-15None69 kPa | F4
2-Jul-19
BBS0000-AO900388047122819DDHepatitis C (HCV) Genotype 5South AfricaSerum2.002.00$250.0072 YFemaleNon-Hispanic<-70C28-Dec-19Roche COBAS AmpliPrep TaqMan1,128,6004-Nov-19NS5B Blast5Genotype$250.00UnknownHepatitis CAbdominal pain, FatigueNoNoTransfusionALT: 36 U/L | AST: 38 U/L | ALP: 79 U/L | Bilirubin: 5 umol/L | Serum Creatinine: 49 umol/L
4-Nov-19
2019-11-04None6.2 kPa
4-Nov-19
BBS0000-AO900388048102219D1Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0070 YFemaleNon-Hispanic<-70C22-Oct-19Xpert Cepheid766,00022-Sep-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoTransfusionALT: 38 U/L | AST: 39 U/L | ALP: 98 U/L | Bilirubin: 17 umol/L | Serum Creatinine: 46 umol/L
22-Sep-19
2019-10-22None8.9 kPa | F2
22-Oct-19
BBS0000-AO900388048102219D2Hepatitis C (HCV) Genotype 5South AfricaSerum2.004.00$250.0070 YFemaleNon-Hispanic<-70C22-Oct-19Xpert Cepheid766,00022-Sep-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoTransfusionALT: 38 U/L | AST: 39 U/L | ALP: 98 U/L | Bilirubin: 17 umol/L | Serum Creatinine: 46 umol/L
22-Sep-19
2019-10-22None8.9 kPa | F2
22-Oct-19
BBS0000-AO900388048102219D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0070 YFemaleNon-Hispanic<-70C22-Oct-19Xpert Cepheid766,00022-Sep-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoTransfusionALT: 38 U/L | AST: 39 U/L | ALP: 98 U/L | Bilirubin: 17 umol/L | Serum Creatinine: 46 umol/L
22-Sep-19
2019-10-22None8.9 kPa | F2
22-Oct-19
BBS0000-AO900388049090718D2Hepatitis C (HCV) Genotype 5South AfricaSerum2.503.00$250.0065 YFemaleUnknown<-70C07-Sep-18Xpert Cepheid951,00031-Jul-18NS5B Blast5Genotype$250.00UnknownChronic Hep C and HIV | HIV Date of onset 4-Nov-2015.FatigueNoNoU/AALT: 91 U/L | AST: 106 U/L | ALP: 197 U/L | Bilirubin: 7 umol/L | Serum Creatinine: 34 umol/L
16-Aug-19
2018-07-31NoneF1
7-Sep-18
BBS0000-AO900388049090718D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0065 YFemaleUnknown<-70C07-Sep-18Xpert Cepheid951,00031-Jul-18NS5B Blast5Genotype$250.00UnknownChronic Hep C and HIV | HIV Date of onset 4-Nov-2015.FatigueNoNoU/AALT: 91 U/L | AST: 106 U/L | ALP: 197 U/L | Bilirubin: 7 umol/L | Serum Creatinine: 34 umol/L
16-Aug-19
2018-07-31NoneF1
7-Sep-18
BBS0000-AO900388049090718D4Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0065 YFemaleUnknown<-70C07-Sep-18Xpert Cepheid951,00031-Jul-18NS5B Blast5Genotype$250.00UnknownChronic Hep C and HIV | HIV Date of onset 4-Nov-2015.FatigueNoNoU/AALT: 91 U/L | AST: 106 U/L | ALP: 197 U/L | Bilirubin: 7 umol/L | Serum Creatinine: 34 umol/L
16-Aug-19
2018-07-31NoneF1
7-Sep-18
BBS0000-AO900388052112718D2Hepatitis C (HCV) Genotype 5South AfricaSerum2.004.00$250.0041 YFemaleUnknown<-70C27-Nov-18Xpert Cepheid1,000,00028-Aug-18Innogenetics Versant HCV5Genotype$250.00UnknownChronic Hepatitis CNo symptomsNoNoU/AALT: 19 U/L | AST: 17 U/L | ALP: 152 U/L | Bilirubin: 6 umol/L | Serum Creatinine: 59 umol/L
20-Nov-18
2018-08-28NoneF1
27-Nov-18
BBS0000-AO900388052112718D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0041 YFemaleUnknown<-70C27-Nov-18Xpert Cepheid1,000,00028-Aug-18Innogenetics Versant HCV5Genotype$250.00UnknownChronic Hepatitis CNo symptomsNoNoU/AALT: 19 U/L | AST: 17 U/L | ALP: 152 U/L | Bilirubin: 6 umol/L | Serum Creatinine: 59 umol/L
20-Nov-18
2018-08-28NoneF1
27-Nov-18
BBS0000-AO900388052112718D4Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0041 YFemaleUnknown<-70C27-Nov-18Xpert Cepheid1,000,00028-Aug-18Innogenetics Versant HCV5Genotype$250.00UnknownChronic Hepatitis CNo symptomsNoNoU/AALT: 19 U/L | AST: 17 U/L | ALP: 152 U/L | Bilirubin: 6 umol/L | Serum Creatinine: 59 umol/L
20-Nov-18
2018-08-28NoneF1
27-Nov-18
BBS0000-AO900388065090319D1Hepatitis C (HCV) Genotype 5South AfricaSerum3.004.00$250.0054 YFemaleNon-Hispanic<-70C03-Sep-19Xpert Cepheid113,0006-Aug-19NS5B Blast5Genotype$250.00UnknownHepatitis CFatigueNoNoTransfusionALT: 37 U/L | AST: 3 U/L | ALP: 120 U/L | Bilirubin: 8 umol/L | Serum Creatinine: 62 umol/L
6-Aug-19
2019-08-06NoneF4
6-Aug-19
BBS0000-AO900388065090319D2Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0054 YFemaleNon-Hispanic<-70C03-Sep-19Xpert Cepheid113,0006-Aug-19NS5B Blast5Genotype$250.00UnknownHepatitis CFatigueNoNoTransfusionALT: 37 U/L | AST: 3 U/L | ALP: 120 U/L | Bilirubin: 8 umol/L | Serum Creatinine: 62 umol/L
6-Aug-19
2019-08-06NoneF4
6-Aug-19
BBS0000-AO900388065090319D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0054 YFemaleNon-Hispanic<-70C03-Sep-19Xpert Cepheid113,0006-Aug-19NS5B Blast5Genotype$250.00UnknownHepatitis CFatigueNoNoTransfusionALT: 37 U/L | AST: 3 U/L | ALP: 120 U/L | Bilirubin: 8 umol/L | Serum Creatinine: 62 umol/L
6-Aug-19
2019-08-06NoneF4
6-Aug-19
BBS0000-AO900388066071718D2Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0060 YMaleNon-Hispanic<-70C17-Jul-18Xpert Cepheid12,70017-Jul-18NS5B Sequence5Genotype$250.00UnknownChronic Hepatitis CNo symptomsNoNoU/AALT: 54 U/L | AST: 40 U/L | ALP: 94 U/L | Bilirubin: 5 umol/L | Serum Creatinine: 40 umol/L
17-Jul-18
2017-11-08None7.6 kPa | F1 F2
17-Jul-18
BBS0000-AO900388066071718D4Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0060 YMaleNon-Hispanic<-70C17-Jul-18Xpert Cepheid12,70017-Jul-18NS5B Sequence5Genotype$250.00UnknownChronic Hepatitis CNo symptomsNoNoU/AALT: 54 U/L | AST: 40 U/L | ALP: 94 U/L | Bilirubin: 5 umol/L | Serum Creatinine: 40 umol/L
17-Jul-18
2017-11-08None7.6 kPa | F1 F2
17-Jul-18
BBS0000-AO900388067031219D1Hepatitis C (HCV) Genotype 5South AfricaSerum3.004.00$250.0039 YMaleNon-Hispanic<-70C12-Mar-19Xpert Cepheid437,19712-Mar-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoU/AALT: 80 U/L | AST: 37 U/L | ALP: 87 U/L | Bilirubin: 10 umol/L | Serum Creatinine: 89 umol/L
12-Mar-19
2019-03-12NoneF1
14-Mar-19
BBS0000-AO900388067031219D2Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0039 YMaleNon-Hispanic<-70C12-Mar-19Xpert Cepheid437,19712-Mar-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoU/AALT: 80 U/L | AST: 37 U/L | ALP: 87 U/L | Bilirubin: 10 umol/L | Serum Creatinine: 89 umol/L
12-Mar-19
2019-03-12NoneF1
14-Mar-19
BBS0000-AO900388067031219D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0039 YMaleNon-Hispanic<-70C12-Mar-19Xpert Cepheid437,19712-Mar-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsNoNoU/AALT: 80 U/L | AST: 37 U/L | ALP: 87 U/L | Bilirubin: 10 umol/L | Serum Creatinine: 89 umol/L
12-Mar-19
2019-03-12NoneF1
14-Mar-19
BBS0000-AO900388069070918DDHepatitis C (HCV) Genotype 5South AfricaSerum4.004.00$250.0061 YFemaleNon-Hispanic<-70C09-Jul-18Roche COBAS AmpliPrep TaqMan11,20026-Jun-18NS5B Sequence5Genotype$250.00UnknownHepatitis CJoint painNoNoTransfusionALT: 33 U/L | AST: 45 U/L | ALP: 107 U/L | Bilirubin: 8 umol/L | Serum Creatinine: 82 umol/L
26-Jun-18
2018-06-26NoneF4 | Cirrhosis
9-Jul-18
BBS0000-AO900388070071619D2Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0061 YMaleNon-Hispanic<-70C16-Jul-19Xpert Cepheid102,00016-Jul-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsYesNoTransfusion HemophiliaALT: 38 U/L | AST: 32 U/L | ALP: 75 U/L | Bilirubin: 11 umol/L | Serum Creatinine: 104 umol/L
2-Jul-19
2019-07-02None48 kPa | F4
16-Jul-19
BBS0000-AO900388070071619D3Hepatitis C (HCV) Genotype 5South AfricaSerum1.00$250.0061 YMaleNon-Hispanic<-70C16-Jul-19Xpert Cepheid102,00016-Jul-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsYesNoTransfusion HemophiliaALT: 38 U/L | AST: 32 U/L | ALP: 75 U/L | Bilirubin: 11 umol/L | Serum Creatinine: 104 umol/L
2-Jul-19
2019-07-02None48 kPa | F4
16-Jul-19
BBS0000-AO900388070071619D4Hepatitis C (HCV) Genotype 5South AfricaSerum3.004.00$250.0061 YMaleNon-Hispanic<-70C16-Jul-19Xpert Cepheid102,00016-Jul-19NS5B Blast5Genotype$250.00UnknownHepatitis CNo symptomsYesNoTransfusion HemophiliaALT: 38 U/L | AST: 32 U/L | ALP: 75 U/L | Bilirubin: 11 umol/L | Serum Creatinine: 104 umol/L
2-Jul-19
2019-07-02None48 kPa | F4
16-Jul-19
BBS0005-AO900079163082217DDHepatitis C (HCV) Genotype 5South Africa0.5 mL Serum1.004.00$250.0062 YFemaleUnknown<-70C22-Aug-17Roche1,838 IU/mLViral LoadSiemens Versant Lipa5Genotype$250.00UnknownFatigueNoNoTransfusionALT: 17 U/L | AST: 23 U/L | ALP: 87 | Bilirubin: 8 umol/L | Serum Creatinine: | 58 umol/L | Fibroscan F2 |
17-Aug-17
22-Mar-17Hepatitis C
BBS0005-CQ900060037031114DDHepatitis C (HCV) Genotype 5South Africa0.5 mL Serum1.003.00$250.0046 YMaleNon-Hispanic<-70C11-Mar-14Method Not Available172,128 IU/mLMethod Not Available5a$250.00UnknownEnd stage renal failure (Dec-2004); Previous renal transplant 1989; TB is spine 2004 (blind from meds)UnknownImmune due to natural exposureUnknownALT: 36; AST: 19; ALP: 76; Bilirubin: 1 umol/L
BBS0005-CQ900060038082313DDHepatitis C (HCV) Genotype 5South Africa0.5 mL Serum1.004.00$250.0061 YFemaleNon-Hispanic<-70C23-Aug-13Method Not Available365,249 IU/mLMethod Not Available5a$250.00UnknownBack pains due to kidneysYesNoUnknownALT: 14; AST: 25; ALP: 279; Bilirubin: 6 umol/L; Serum Creatinine: 615 umol/LHBsAg-; HBcAb IgM-; HBcAb Total-; HBsAb-
BBS0005-CQ900060039031114DDHepatitis C (HCV) Genotype 5South Africa0.5 mL Serum0.754.00$250.0081 YFemaleNon-Hispanic<-70C11-Mar-14Method Not Available1,501,746 IU/mLMethod Not Available5a$250.00UnknownPain in kidneys; Weak feet and kneesNoNoUnknownALT: 26; AST: 23; ALP: 161; Bilirubin: 8 umol/L; Serum Creatinine: 158 umol/L; Stable Chronic Hepatitis
DSP3800-BK900047442050713DDHepatitis C (HCV) Genotype 5United StatesDouble Spun Plasma1.502.00$250.0053 YMaleNon-Hispanic<-70C07-May-13Roche cobas AmpliPrep6,526,520 IU/mLVersant HCv5a$250.00UnknownALT: 30; AST: 23; ALP: 82; Bilirubin: 0.3 mg/dL
Hepatitis Serology

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.